• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAR 4.05% 38.5¢

PARADIGM BIOPHARMACEUTICALS LIMITED..

Paradigm Biopharmaceuticals Limited is a late-stage drug development company. It is... Paradigm Biopharmaceuticals Limited is a late-stage drug development company. It is engaged in researching and developing therapeutic products for human use. It is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) for the treatment of osteoarthritis (OA). Pentosan polysulfate sodium is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucurono-xylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). It develops PPS under the brand name Zilosul. PPS clears cellular and tissue accumulation of GAGs. PPS also inhibits the synthesis of the metalloproteinase, MMP-3 (Troeberg) involved in degrading cartilage. PPS also include treatment of joint function, mobility, and pain in patients with mucopolysaccharidoses (MPS); treating alphavirus-induced arthralgia (such as Ross River virus and Chikungunya); chronic heart failure (HF) and acute respiratory distress syndrome (ARDS).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAR
General OA media and info
8 9 10
21:02 561 205K
21:02 Last post  Babbanap Comments Created with Sketch.  561  Views Created with Sketch.  205K 
PAR
IPPS and the most important membrane
18/03/24 19 6.9K
18/03/24 Last post  Huts7 Comments Created with Sketch.  19  Views Created with Sketch.  6.9K 
PAR
Chart
69 70 71
15/03/24 4.2K 3.7M
TRENDING NEWS

BREAKING: RBA keeps interest rate on hold at 4.35% in line with expectations

NEWS
19 Mar 2024
15/03/24 Last post  danny59 Comments Created with Sketch.  4.2K  Views Created with Sketch.  3.7M 
PAR
research reports and media
66 67 68
13/03/24 4.0K 1.8M
13/03/24 Last post  oxxa23 Comments Created with Sketch.  4.0K  Views Created with Sketch.  1.8M 
PAR
What do they really want? An MPS example...
13/03/24 9 4.8K
13/03/24 Last post  jcurve Comments Created with Sketch.  9  Views Created with Sketch.  4.8K 
PAR 12/03/24 5 2.3K
12/03/24 Last post  pseudonymABC Comments Created with Sketch.  5  Views Created with Sketch.  2.3K 
PAR
where are we at at the moment ?
10/03/24 40 12K
10/03/24 Last post  Mozzarc Comments Created with Sketch.  40  Views Created with Sketch.  12K 
PAR
OARSI 2024
09/03/24 42 14K
09/03/24 Last post  Beaza79 Comments Created with Sketch.  42  Views Created with Sketch.  14K 

See All Discussions arrow Created with Sketch.

Timeline

Change of Director's Interest Notice
08 Mar 13:18
 
Change of Director's Interest Notice
08 Mar 13:17
 
Final Director's Interest Notice
06 Mar 09:27
 
Initial Director's Interest Notice
04 Mar 11:20
 
Paradigm Board Changes
04 Mar 09:14
 
Notification regarding unquoted securities - PAR
29 Feb 10:22
 
View More arrow Created with Sketch.
(20min delay)
Last
38.5¢
Change
0.015(4.05%)
Mkt cap ! $134.9M
Open High Low Value Volume
37.0¢ 38.5¢ 37.0¢ $33.53K 87.66K

Buyers (Bids)

No. Vol. Price($)
2 23965 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.5¢ 55499 4
View Market Depth
Last trade - 16.10pm 19/03/2024 (20 minute delay) ?
Last
37.5¢
  Change
0.015 ( 1.55 %)
Open High Low Volume
38.0¢ 38.0¢ 37.5¢ 11948
Last updated 15.40pm 19/03/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.